Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2001

Main Data: 31/12 Year 2001
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 336.30
– gross margin 156.80
– total operating cost 107.41
– net operating profit 44.87
– financial expenses, net 6.49
– net income before taxes 20.45

 

Consolidated balance sheet Millions/Euro
– operating capital 87.59
– fixed assets, net 113.28
– reserves and MLT non financial payables – 26.22
– net financial position – 75.14
– stockholders’ equity 99.51

 

Other information Millions/Euro
– depreciation 14.43
– R & D expenses 18.81

 

  Euro
Dividend per share 0.36

 

  No.
Employees 2,232

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2001
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 125.42
– gross margin 57.23
– total operating cost 53.99
– net operating profit 3.24
– financial expenses, net 3.07
– net income before taxes – 0.33

 

Consolidated balance sheet Millions/Euro
– operating capital 93.40
– fixed assets, net 108.93
– reserves and MLT non financial payables – 24.37
– net financial position – 99.00
– stockholders’ equity 78.95

 

Other information Millions/Euro
– depreciation 6.71
– R & D expenses 10.42

 

  No.
Employees 2,209

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2001
  Millions/Euro  
tea, herbs & coffee 49.60 14.75%
pharmaceuticals packaging 185.30 55.10%
pharmaceuticals processing 101.40 30.15%
Total 336.30 100.00%

 

Net Sales by Country: Year 2001
  Millions/Euro  
E.U. (excluding Italy) 127.88 38.03%
Other European countries 31.02 9.22%
North America 63.54 18.89%
Asia & Middle East 53.93 16.04%
Other countries 44.09 13.11%
Total exports 320.46 95.29%
Italy 15.84 4.71%
Total 336.30 100.00%